Profile of Immunoglobulin G N-Glycome in COVID-19 Patients: A Case-Control Study

H Hou, H Yang, P Liu, C Huang, M Wang, Y Li… - Frontiers in …, 2021 - frontiersin.org
Coronavirus disease 2019 (COVID-19) remains a major health challenge globally. Previous
studies have suggested that changes in the glycosylation of IgG are closely associated with …

COVID-19: infection or autoimmunity

T Icenogle - Frontiers in immunology, 2020 - frontiersin.org
The clinical and laboratory features of COVID-19 are reviewed with attention to the
immunologic manifestations of the disease. Recent COVID-19 publications describe a …

Potent SARS-CoV-2-specific T cell immunity and low anaphylatoxin levels correlate with mild disease progression in COVID-19 patients

E Lafon, G Diem, C Witting, V Zaderer… - Frontiers in …, 2021 - frontiersin.org
T cells play a fundamental role in the early control and clearance of many viral infections of
the respiratory system. In SARS-CoV-2-infected individuals, lymphopenia with drastically …

[HTML][HTML] Molecular dynamics simulation and docking analysis of NF-κB protein binding with sulindac acid

S Ahmad, P Bhanu, J Kumar, RK Pathak, D Mallick… - …, 2022 - ncbi.nlm.nih.gov
It is of interest to document the Molecular Dynamics Simulation and docking analysis of NF-
κB target with sulindac sodium in combating COVID-19 for further consideration. Sulindac is …

Can nutraceuticals assist treatment and improve covid-19 symptoms?

A Alesci, M Aragona, N Cicero… - Natural Product …, 2022 - Taylor & Francis
Viral diseases have always played an important role in public and individual health. Since
December 2019, the world is facing a pandemic of SARS-CoV-2, a coronavirus that results …

National psoriasis foundation COVID-19 task force guidance for management of psoriatic disease during the pandemic: Version 1

JM Gelfand, AW Armstrong, S Bell, GL Anesi… - Journal of the American …, 2020 - Elsevier
Objective To provide guidance about management of psoriatic disease during the
coronavirus disease 2019 (COVID-19) pandemic. Study design A task force (TF) of 18 …

Insights from nanotechnology in COVID-19: prevention, detection, therapy and immunomodulation

P Singh, D Singh, P Sa, P Mohapatra, A Khuntia… - …, 2021 - Taylor & Francis
The outbreak of SARS-CoV-2 infection has presented the world with an urgent demand for
advanced diagnostics and therapeutics to prevent, treat and control the spread of infection …

Dynamics of SARS-CoV-2 shedding in the respiratory tract depends on the severity of disease in COVID-19 patients

D Munker, A Osterman, H Stubbe… - European …, 2021 - Eur Respiratory Soc
A fraction of COVID-19 patients progress to a severe disease manifestation with respiratory
failure and the necessity of mechanical ventilation. Identifying patients at risk is critical for …

Long noncoding RNAs as emerging regulators of COVID-19

Q Yang, F Lin, Y Wang, M Zeng, M Luo - Frontiers in immunology, 2021 - frontiersin.org
Coronavirus disease 2019 (COVID-19), which has high incidence rates with rapid rate of
transmission, is a pandemic that spread across the world, resulting in more than 3,000,000 …

Anti-infective, anti-inflammatory, and immunomodulatory properties of breast milk factors for the protection of infants in the pandemic from COVID-19

PA Quitadamo, L Comegna, P Cristalli - Frontiers in Public Health, 2021 - frontiersin.org
COVID-19 pandemic since the end of 2019 spreads worldwide, counting millions of victims.
The viral invasion, systemic inflammation, and consequent organ failure are the gravest …